Crispr Therapeutics shares owned by CIBC World Markets
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by CIBC World Markets
from 13F filings
Historical chart of CIBC World Markets investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by CIBC World Markets consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by CIBC World Markets
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $534k | 11k | 46.99 |
| 2024-06-30 | $675k | 13k | 54.00 |
| 2024-03-31 | $905k | 13k | 68.17 |
| 2023-09-30 | $465k | 10k | 45.36 |
| 2023-06-30 | $514k | 9.2k | 56.14 |
| 2023-03-31 | $423k | 9.4k | 45.22 |
| 2022-12-31 | $364k | 8.9k | 40.70 |
| 2022-09-30 | $586k | 9.0k | 65.39 |
| 2022-06-30 | $570k | 9.4k | 60.78 |
| 2022-03-31 | $524k | 8.4k | 62.72 |
| 2021-12-31 | $424k | 5.6k | 75.80 |
| 2021-09-30 | $720k | 6.4k | 111.91 |
| 2021-06-30 | $1.9M | 12k | 161.93 |
| 2021-03-31 | $513k | 4.2k | 121.97 |
| 2020-12-31 | $345k | 2.3k | 153.20 |
| 2018-06-30 | $824k | 14k | 58.74 |
| 2018-03-31 | $1.2M | 25k | 45.70 |